Contrary to our findings, He et al. demonstrated a positive association between TIM-3 expression and BRAF V600E mutations in CRC, a result further supported by analyses of public datasets, such as TCGA and GEO, which also reported higher TIM-3 expression in BRAF-mutated tumors [80,81]. The gene discussed is HAVCR2; the disease is colorectal carcinoma.